Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Maat Pharma SA
MAATCurrent price
7.6 EUR
+0.08 EUR (+1.06%)
Last closed
7.78 EUR
Company
www.maatpharma.com
ISIN
FR0012634822
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Paris
Capitalization
109 642 584 EUR
Yield for 12 month
-1.30 %
1Y
3Y
5Y
10Y
15Y
MAAT
MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France. Address: 70 Avenue Tony Garnier, Lyon, France, 69007
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15 EURP/E ratio
–Dividend Yield
–Current Year
+2 254 681 EUR
Last Year
+1 447 125 EUR
Current Quarter
+870 804 EUR
Last Quarter
+870 804 EUR
Current Year
+793 389 EUR
Last Year
+1 104 066 EUR
Current Quarter
+599 090 EUR
Last Quarter
+599 090 EUR
Key Figures MAAT
1 year
3 years
5 years
10 years
EBITDA
-24 229 724 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-29.99 %
PEG Ratio
–
Return On Equity TTM
-84.85 %
Wall Street Target Price
15 EUR
Revenue TTM
2 601 788 EUR
Book Value
1.86 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
24.9 %
Dividend Yield
–
Gross Profit TTM
797 437 EUR
Earnings per share
-1.72 EUR
Diluted Eps TTM
-1.72 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MAAT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MAAT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation MAAT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
44.0332
Price Sales TTM
42.1412
Enterprise Value EBITDA
-7.424
Price Book MRQ
5.2931
Financials MAAT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MAAT
For 52 weeks
6.38 EUR
10.02 EUR
50 Day MA
7.41 EUR
Shares Short Prior Month
–
200 Day MA
7.94 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart